Drugs down-regulating the STING pathway either upstream (like aspirin and IVIgs, and Vitamin -D), or downstream (like IL-6 inhibitors or inhibitors of the JAK-STAT pathway) could be beneficial in COVID-19, and perhaps also in some KD. This evidence concerns the gene SOAT1 and COVID-19.